Accession Number: | 0000886163-21-000071 |
Date: | 2021-05-11 |
Issuer: | LIGAND PHARMACEUTICALS INC (LGND) |
Original Submission Date: |
KOZARICH JOHN W
3911 SORRENTO VALLEY BOULEVARD, STE 110
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-05-11 | M | 4,835 | a | $10.12 | 34,543 | direct | ||
COMMON STOCK | 2021-05-11 | F | 391 | d | $128.56 | 34,152 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 10.12 | 2021-05-11 | deemed execution date | M | 4,835 (d) | 2012-06-01 | common stock 4,835 | $10.12 | 0 | direct |
ID | footnote |
---|---|
f1 | represents shares withheld by the issuer in payment of the exercise price of options. |
f2 | acquired by a grant of the board of directors of the company at their annual meeting on june 01, 2011, and fully vested on the first anniversary of the grant date. |